Related references
Note: Only part of the references are listed.Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation
Olga Ostrovsky et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis
Rachel W. Li et al.
ARTHRITIS AND RHEUMATISM (2008)
Polymorphisms of cytokine and innate immunity genes and GVHD
A. M. Dickinson et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Acute GvHD: pathogenesis and classification
L. M. Ball et al.
BONE MARROW TRANSPLANTATION (2008)
Function of heparanase in prostate turnorigenesis: Potential for therapy
Immanuel Lerner et al.
CLINICAL CANCER RESEARCH (2008)
Fragments of extracellular matrix as mediators of inflammation
Tracy L. Adair-Kirk et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment
Ghada Abboud-Jarrous et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies
O. Ostrovsky et al.
LEUKEMIA (2007)
Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: Fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan
A. Shimoni et al.
LEUKEMIA (2007)
Heparanase: a target for drug discovery in cancer and inflammation
E. A. McKenzie
BRITISH JOURNAL OF PHARMACOLOGY (2007)
New directions in the genomics of allogeneic hematopoietic stem cell transplantation
Charles G. Mullighan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Non-Anticoagulant Heparins and Inhibition of Cancer
Benito Casu et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2007)
Heparanase upregulation by colonic epithelium in inflammatory bowel disease
Matti Waterman et al.
MODERN PATHOLOGY (2007)
Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation
F. E. Bertinetto et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2006)
Role of endothelial heparanase in delayed-type hypersensitivity
E Edovitsky et al.
BLOOD (2006)
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity
A Shimoni et al.
LEUKEMIA (2006)
Genetics of risk factors for graft-versus-host disease
EW Petersdorf et al.
SEMINARS IN HEMATOLOGY (2006)
Pathophysiology of graft-versus-host disease
JLM Ferrara et al.
SEMINARS IN HEMATOLOGY (2006)
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Neta Ilan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation:: synergism between IL-10 genotype of patient and IL-10 receptor β genotype of donor
MT Lin et al.
BLOOD (2005)
Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time
A Gratwohl et al.
BONE MARROW TRANSPLANTATION (2005)
Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase
G Abboud-Jarrous et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Conditional signaling by Toll-like receptor 4
GJ Brunn et al.
FASEB JOURNAL (2005)
Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis
E Edovitsky et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation
E Holler et al.
BLOOD (2004)
Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review
F Baron et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2004)
Heparan sulfate proteoglycans and heparanase - partners in osteolytic tumor growth and metastasis
RD Sanderson et al.
MATRIX BIOLOGY (2004)
Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic cell transplantation
M Lin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Polymorphisms of interleukin-1α constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation
H Cullup et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
M Mielcarek et al.
BLOOD (2003)
Immunobiology of acute graft-versus-host disease
P Reddy et al.
BLOOD REVIEWS (2003)
Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation
V Rocha et al.
BLOOD (2002)
Heparanase expression in human leukemias is restricted to acute myeloid leukemias
M Bitan et al.
EXPERIMENTAL HEMATOLOGY (2002)
Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation
J Cavet et al.
BLOOD (2001)
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis
I Vlodavsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Heparanase as mediator of angiogenesis: mode of action
M Elkin et al.
FASEB JOURNAL (2001)
Share Paper
